Atlas FDA

Anika Therapeutics, Inc.

6 FDA 510(k) clearances · Recalling firm

Sort:Newest firstOldest first

◉ Watch Anika Therapeutics, Inc.

RecordFirmDate
Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. recall (Z-1382-05)Anika Therapeutics, Inc.2005-08-23
ShellGell Sodium Hyaluronate 0.8mL Syringe, 12 mg/mL. Sterile. Rx. For intraocular use. Pr recall (Z-1383-05)Anika Therapeutics, Inc.2005-08-23
Amvisc Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: 59051 recall (Z-1384-05)Anika Therapeutics, Inc.2005-08-23
Amvisc Sodium Hyaluronate 0.8 mL. Bausch & Lomb, Inc., Rochester, NY Product Numbr: 59081 recall (Z-1385-05)Anika Therapeutics, Inc.2005-08-23
Amvisc Plus Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: recall (Z-1386-05)Anika Therapeutics, Inc.2005-08-23
Amvisc Plus Sodium Hyaluronate 0.8 mL. Bausch & Lomb, Inc., Rochester, NY Product Number: recall (Z-1387-05)Anika Therapeutics, Inc.2005-08-23

Track Anika Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.